Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 
TPCE Banner

Live (Johnson City) - HIV & HCV For East Tennessee Providers


This live program will be held in-person in Johnson CIty, TN. There is no charge for this program. The TPCE website is only for claiming credit after attendance in this program. Please register for the event through the Southeast AIDS Education and Training Center. Please click here for more information. 

Date: Jan 25, 2018 08:00 AM - Jan 26, 2018 04:15 PM

Location: Carnegie Hotel, 1216 W State of Franklin Road, Johnson City, TN

Fee

$0.00

CE Hours

14.00

Activity Type

  • Knowledge

Accreditation(s)

Accreditation Council for Pharmacy Education
The Tennessee Pharmacists Consortium for Education is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

 

 

 

   

Objectives

  • Identify risk factors for HCV which indicate that a patient should be tested.
  • Discuss the epidemiology of HCV and pretreatment evaluations.
  • Describe updates in ART and best practices for adherence counseling.
  • Classify the different HCV genotypes and recommended treatment regimens for each.
  • Discuss appropriate monitoring while a patient is undergoing HCV treatment.
  • Identify pharmacological considerations of HCV Treatment.
  • Discuss the elements of providing culturally competent care to transgender patients.
  • Describe post-therapy monitoring procedures.
  • Apply knowledge about the Opioid Epidemic and substance use disorders as they relate to HCV and HIV.

Activity Number

0575-0000-18-005-L02-P
Date: 01/25/18
Time: 08:00 AM - 04:15 PM

CE Hours

7.00
   

 

   

Objectives

  • Identify risk factors for HCV which indicate that a patient should be tested.
  • Discuss the epidemiology of HCV and pretreatment evaluations.
  • Describe updates in ART and best practices for adherence counseling.
  • Classify the different HCV genotypes and recommended treatment regimens for each.
  • Discuss appropriate monitoring while a patient is undergoing HCV treatment.
  • Identify pharmacological considerations of HCV Treatment.
  • Discuss the elements of providing culturally competent care to transgender patients.
  • Describe post-therapy monitoring procedures.
  • Apply knowledge about the Opioid Epidemic and substance use disorders as they relate to HCV and HIV.

Activity Number

0575-0000-18-006-L02-P
Date: 01/26/18
Time: 08:00 AM - 04:15 PM

CE Hours

7.00